Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
12/16/2004 | US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy |
12/16/2004 | US20040253233 genetic engineered chimeric and humanized antibodies obtained from murine monoclonal antibody P3 (MAb P3) and its antiidiotypic antibodies, used as antitumor agents |
12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
12/16/2004 | US20040253214 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
12/16/2004 | US20040253209 Method and system for myocardial infarction repair |
12/16/2004 | US20040253204 terpolymer of a hydrophobic acrylic ester, an aminoalkyl acrylate, and a hydroxyalkyl acrylate as a protonic neutral hydrophilic monomer; methyl methacrylate, dimethylaminoethyl methacrylate and 2-hydroxyethyl methacrylate; efficiency; blood transfusions |
12/16/2004 | DE10322986A1 Ex-vivo gehaltene, vitale Mammalia-Herzgewebe-Zellen, Verfahren zur deren Gewinnung und Kultivierung und deren Verwendung Ex vivo held vital mammalian heart tissue cells, processes for their production and cultivation and their use |
12/16/2004 | CA2536472A1 Epas1 gene transfer to improve cell therapy |
12/16/2004 | CA2531569A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stemcell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transformation introducing the gene |
12/16/2004 | CA2528851A1 Extracellular aspergillus polypeptides |
12/16/2004 | CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production |
12/16/2004 | CA2528500A1 Porcine cmp-n-acetylneuraminic acid hydroxylase gene |
12/16/2004 | CA2528248A1 Neural crest stem cells and uses thereof |
12/16/2004 | CA2528157A1 Cell-containing preparations |
12/16/2004 | CA2528131A1 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
12/16/2004 | CA2528115A1 Selection and propagation of progenitor cells |
12/16/2004 | CA2528046A1 Flavivirus replicon packaging system |
12/16/2004 | CA2527914A1 Improved secretion of neublastin |
12/16/2004 | CA2527733A1 Integrated microfluidic sperm isolation and insemination device |
12/16/2004 | CA2527728A1 Micropositioning cells for tissue engineering |
12/16/2004 | CA2526789A1 Cells used as carriers for bacteria |
12/16/2004 | CA2526509A1 Connective tissue growth factor antibodies |
12/16/2004 | CA2525401A1 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
12/16/2004 | CA2524910A1 Therapeutical composition containing dendritic cells and use thereof |
12/16/2004 | CA2524329A1 Anti-hgf-r antibodies and their use |
12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
12/15/2004 | EP1486505A1 Angiotensin derivatives |
12/15/2004 | EP1485714A2 Methods for the detection of prion proteins |
12/15/2004 | EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
12/15/2004 | EP1485491A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
12/15/2004 | EP1485487A2 Cartilage regeneration using chondrocyte and tgf-beta |
12/15/2004 | EP1485486A2 Optimizing glycan processing in plants |
12/15/2004 | EP1485485A1 Transdifferentiation of cells and tissues |
12/15/2004 | EP1485482A1 Inhibition of the beta3 subunit of l-type ca 2+ channels |
12/15/2004 | EP1485481A2 Fluorescent protein from aequorea coerulescens and uses thereof |
12/15/2004 | EP1485479A2 Stem cell culture |
12/15/2004 | EP1485477A2 Novel type-1 cytokine receptor glm-r |
12/15/2004 | EP1485475A1 Hybrid and single chain meganucleases and use thereof |
12/15/2004 | EP1485471A1 Alcohol dehydrogenases with high solvent and temperature stability |
12/15/2004 | EP1485467A2 Recombinant expression vectors for functional na sb v /sb 1.9 sodium channels |
12/15/2004 | EP1485464A2 Methods of inducing differentiation in ex vivo expanded stem cells |
12/15/2004 | EP1485415A2 Neoplasm specific antibodies and uses thereof |
12/15/2004 | EP1485410A1 Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseases |
12/15/2004 | EP1485397A2 Trans-splicing mediated imaging of gene expression |
12/15/2004 | EP1485124A2 Method of inducing an enhanced immune response against hiv |
12/15/2004 | EP1485108A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
12/15/2004 | EP1484959A2 Nucleic acid constructs and methods for producing altered seed oil compositions |
12/15/2004 | EP1453954A4 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
12/15/2004 | EP1442305A4 Sensitivity controls for blood serology prepared from modified cells |
12/15/2004 | EP1404845B1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
12/15/2004 | EP1128838A4 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
12/15/2004 | EP1121599B1 Detection and quantification of vancomycin in biological fluids |
12/15/2004 | EP1121448B1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
12/15/2004 | EP1015025B1 T-cell vaccination for the treatment of multiple sclerosis |
12/15/2004 | EP0988391B1 Recombinant adenoviral vectors comprising a splicing sequence |
12/15/2004 | EP0968290B1 Anti-alphavbeta3 humanized monoclonal antibodies |
12/15/2004 | EP0956304B1 Dendritic cell-specific antibodies |
12/15/2004 | EP0638088B1 Hybrid human/porcine factor viii |
12/15/2004 | CN1555488A Lymphatic endothelial cells materials and methods |
12/15/2004 | CN1555417A Paramyxovirus vector for gene transfer to the cardiovascular system |
12/15/2004 | CN1555416A Nucleic acid sequences encoding enantioselective amidases |
12/15/2004 | CN1555415A Synthetic HCV envelope proteins and their use for vaccination |
12/15/2004 | CN1555414A Plant-derived resistance gene |
12/15/2004 | CN1555413A Vascular tissue preferred promoters |
12/15/2004 | CN1555411A Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
12/15/2004 | CN1555383A Novel peptide, novel adsorbent, adsorption unit and adsorption method |
12/15/2004 | CN1555268A Therapeutic agents comprising pro-apoptotic proteins |
12/15/2004 | CN1554764A Recombinant mva virus, and the use thereof |
12/15/2004 | CN1554750A Subtilase variants and compositions |
12/15/2004 | CN1554748A Method for preparing megakaryocytic preparation by amplifying macronucleus ancestral cell and mature megacaryocyte and use |
12/15/2004 | CN1180080C Preprartion method of improved hepatoma murine monoclonal antibody |
12/15/2004 | CN1180079C Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
12/14/2004 | US6831217 C3 plants expressing photosynthetic enzyme of C4 plants |
12/14/2004 | US6831215 Hybrid maize plant and seed 34G13 |
12/14/2004 | US6831207 For incorporating into porphyrin during chlorophyll biosynthesis; qualitative/quantitative analysis |
12/14/2004 | US6831206 Nucleotide sequences coding polypeptides for use in animal feeds |
12/14/2004 | US6831168 Aldehyde oxidase gene derived from plant and utilization thereof |
12/14/2004 | US6831161 For chromatography; genetic engineering; albumin-binding protein |
12/14/2004 | US6831151 Mast cell-specific signal transducing molecules and cDNAs thereof |
12/14/2004 | US6831062 Bacillus thuringiensis toxins with improved activity |
12/14/2004 | US6831060 Nucleotide sequences coding erythropoietin protein for use in the treatment of blood disorders |
12/14/2004 | US6830930 Nucleic acid encoding GAI gene of arabidopsis thaliana |
12/14/2004 | US6830928 Plant micropropagation and germplasm storage |
12/14/2004 | US6830927 Common neural progenitor for the CNS and PNS |
12/14/2004 | US6830924 For anticarcinogenic drugs; kits |
12/14/2004 | US6830917 Method of isolation and purification of trypsin from pronase protease and use thereof |
12/14/2004 | US6830914 RGS-containing molecules and uses thereof |
12/14/2004 | US6830913 ABCB9 transporter and uses thereof |
12/14/2004 | US6830907 Mutants of Mycobacterium vaccae-derived formate dehydrogenase and uses thereof |
12/14/2004 | US6830894 Compounds and methods for modulating claudin-mediated functions |
12/14/2004 | US6830762 Autologous fibrin sealant and method for making the same |
12/14/2004 | US6830749 Antitumor agents; gene therapy |
12/14/2004 | CA2104957C Redirection of cellular immunity by receptor chimeras |
12/14/2004 | CA2091444C Media for culture of insect cells |
12/14/2004 | CA1341468C Preparation of functional human factor viii |
12/09/2004 | WO2004107243A1 Method for designing dna codes used as information carrier |
12/09/2004 | WO2004106924A2 Testing cell cycle regulation effect of a compound using a hollow fibre cell implant |
12/09/2004 | WO2004106921A2 In vitro platform for screening agents inducing islet cell neogenesis |